These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22876919)

  • 81. Adiponectin in inflammatory and immune-mediated diseases.
    Fantuzzi G
    Cytokine; 2013 Oct; 64(1):1-10. PubMed ID: 23850004
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Adiponectin--it's all about the modifications.
    Simpson F; Whitehead JP
    Int J Biochem Cell Biol; 2010 Jun; 42(6):785-8. PubMed ID: 20044026
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Exploring the Cardio-metabolic Relevance of T-cadherin: A Pleiotropic Adiponectin Receptor.
    Clark JL; Taylor CG; Zahradka P
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):200-206. PubMed ID: 28820074
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy.
    Padmalayam I; Suto M
    Curr Pharm Des; 2013; 19(32):5755-63. PubMed ID: 23448486
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Adiponectin as a regulator of vascular redox state: therapeutic implications.
    Antonopoulos AS; Lee R; Margaritis M; Antoniades C
    Recent Pat Cardiovasc Drug Discov; 2011 May; 6(2):78-88. PubMed ID: 21453253
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of lipid-lowering drugs on adiponectin.
    Perelas A; Tsoulkani A; Perrea D
    Curr Vasc Pharmacol; 2010 Nov; 8(6):836-48. PubMed ID: 20180775
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Targeting adiponectin for cardioprotection.
    Ouchi N; Shibata R; Walsh K
    Expert Opin Ther Targets; 2006 Aug; 10(4):573-81. PubMed ID: 16848693
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Adiponectin in autoimmune diseases.
    Toussirot É; Binda D; Gueugnon C; Dumoulin G
    Curr Med Chem; 2012; 19(32):5474-80. PubMed ID: 22876925
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The role of adiponectin for immune cell function in metabolic diseases.
    Gao M; Cui D; Xie J
    Diabetes Obes Metab; 2023 Sep; 25(9):2427-2438. PubMed ID: 37272314
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The Emerging Role of Adiponectin in Female Malignancies.
    Gelsomino L; Naimo GD; Catalano S; Mauro L; Andò S
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052147
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders.
    Francischetti EA; Dezonne RS; Pereira CM; de Moraes Martins CJ; Celoria BMJ; de Oliveira PAC; de Abreu VG
    Horm Metab Res; 2020 Oct; 52(10):695-707. PubMed ID: 32927496
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Adiponectin: an adipokine with protective features against metabolic syndrome.
    Esfahani M; Movahedian A; Baranchi M; Goodarzi MT
    Iran J Basic Med Sci; 2015 May; 18(5):430-42. PubMed ID: 26124928
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Adiponectin and breast cancer.
    Chen X; Wang Y
    Med Oncol; 2011 Dec; 28(4):1288-95. PubMed ID: 20625941
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.
    Woodward L; Akoumianakis I; Antoniades C
    Br J Pharmacol; 2017 Nov; 174(22):4007-4020. PubMed ID: 27629236
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Adiponectin as a potential biomarker of vascular disease.
    Ebrahimi-Mamaeghani M; Mohammadi S; Arefhosseini SR; Fallah P; Bazi Z
    Vasc Health Risk Manag; 2015; 11():55-70. PubMed ID: 25653535
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin.
    Jung HN; Jung CH
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948320
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases.
    Choi HM; Doss HM; Kim KS
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059381
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Protective vascular and myocardial effects of adiponectin.
    Goldstein BJ; Scalia RG; Ma XL
    Nat Clin Pract Cardiovasc Med; 2009 Jan; 6(1):27-35. PubMed ID: 19029992
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Functional Interplay between IGF-1 and Adiponectin.
    Orrù S; Nigro E; Mandola A; Alfieri A; Buono P; Daniele A; Mancini A; Imperlini E
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036907
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases.
    Hu Y; Li W; Cheng X; Yang H; She ZG; Cai J; Li H; Zhang XJ
    Circ Res; 2024 Jun; 135(1):222-260. PubMed ID: 38900855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.